Noninvasive Staging of Non-small Cell Lung Cancer

Darling, 1997, Staging of the patient with small cell lung cancer, Chest Surg Clin N Am, 7, 81 Mountain, 1986, A new international system for staging lung cancer, Chest, 89(suppl), 225s, 10.1378/chest.89.4_Supplement.225S Mountain, 1997, Revisions in the International System for Staging Lung Cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710 Toloza, 2003, Noninvasive staging of non-small cell lung cancer: a review of the current evidence, Chest, suppl, 137s, 10.1378/chest.123.1_suppl.137S Cerfolio, 2005, Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial, Ann Thorac Surg, 80, 1207, 10.1016/j.athoracsur.2005.04.019 Pozo-Rodriquez, 2005, Accuracy of helical computed tomography and (18 F) flourodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer, J Clin Oncol, 23, 8348, 10.1200/JCO.2004.00.6361 Serra, 2006, Routine positron tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC) [abstract], J Clin Oncol, 24, 371s, 10.1200/jco.2006.24.18_suppl.7031 Verhagen, 2004, FDG-PET in staging lung cancer: how does it change the algorithm?, Lung Cancer, 44, 175, 10.1016/j.lungcan.2003.11.007 Bollen, 1994, Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer, Ann Thorac Surg, 58, 158, 10.1016/0003-4975(94)91091-X Ratto, 1990, Improving clinical efficacy of computed tomographic scan in the preoperative assessment of patients with non-small cell lung cancer, J Thorac Cardiovasc Surg, 99, 416, 10.1016/S0022-5223(19)36971-5 Nomori, 2004, The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer, J Thorac Cardiovasc Surg, 127, 1087, 10.1016/j.jtcvs.2003.08.010 Takamochi, 2005, Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients, Lung Cancer, 47, 235, 10.1016/j.lungcan.2004.08.004 Webb, 1991, CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group, Radiology, 178, 705, 10.1148/radiology.178.3.1847239 Cole, 1993, Computerised tomography does not predict N2 disease in patients with lung cancer, Aust N Z J Med, 23, 688, 10.1111/j.1445-5994.1993.tb04728.x Jolly, 1991, Routine computed tomographic scans, selective mediastinoscopy, and other factors in evaluation of lung cancer, J Thorac Cardiovasc Surg, 102, 266, 10.1016/S0022-5223(19)36559-6 Mc Loud, 1992, Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling, Radiology, 182, 319, 10.1148/radiology.182.2.1732943 Yokoi, 1994, Mediastinal lymph node metastasis from lung cancer: evaluation with T1–201 SPECT-comparison with CT, Radiology, 192, 813, 10.1148/radiology.192.3.8058953 Primack, 1994, Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions, Radiology, 193, 795, 10.1148/radiology.193.3.7972827 Aaby, 1995, Mediastinal staging of non-small-cell lung cancer: computed tomography and cervical mediastinoscopy, ORL J Otorhinolaryngol Relat Spec, 57, 279, 10.1159/000276758 Bury, 1997, Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer, Eur Respir J, 10, 2529, 10.1183/09031936.97.10112529 Buccheri, 1996, Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer, Thorax, 51, 359, 10.1136/thx.51.4.359 Bury, 1996, Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer, Eur Respir J, 9, 2560, 10.1183/09031936.96.09122560 Gdeedo, 1997, Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging, Eur Respir J, 10, 1547, 10.1183/09031936.97.10071547 Vansteenkiste, 1998, FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localization of regional lymph node metastases?, Eur J Nucl Med, 25, 1495, 10.1007/s002590050327 Vansteenkiste, 1998, Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients, J Clin Oncol, 16, 2142, 10.1200/JCO.1998.16.6.2142 Suzuki, 1999, Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer, J Thorac Cardiovasc Surg, 117, 593, 10.1016/S0022-5223(99)70340-5 Saunders, 1999, Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer, Ann Thorac Surg, 67, 790, 10.1016/S0003-4975(98)01257-0 Marom, 1999, Staging non-small cell lung cancer with whole-body PET, Radiology, 212, 803, 10.1148/radiology.212.3.r99se21803 Takamochi, 2000, The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer, J Thorac Cardiovasc Surg, 119, 1135, 10.1067/mtc.2000.105830 Pieterman, 2000, Preoperative staging of non-small-cell lung cancer with positron-emission tomography, N Engl J Med, 343, 254, 10.1056/NEJM200007273430404 Osada, 2001, Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer, Jpn J Thorac Cardiovasc Surg, 49, 1, 10.1007/BF02913116 Kamiyoshihara, 2001, Mediastinal lymph node evaluation by computed tomographic scan in lung cancer, J Cardiovasc Surg, 42, 119 Dunagan, 2001, Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer, Chest, 119, 333, 10.1378/chest.119.2.333 Wallace, 2001, Endoscopic ultrasound-guided fine needle aspiration for staging patients with carcinoma of the lung, Ann Thorac Surg, 1861, 10.1016/S0003-4975(01)03205-2 Poncelet, 2001, PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma, Eur J Cardiothorac Surg, 20, 468, 10.1016/S1010-7940(01)00827-2 Laudanski, 2001, The preoperative study of mediastinal lymph nodes metastasis in lung cancer by endoscopic ultrasonography (EUS) and helical computed tomography (CT), Lung Cancer, 34, s123, 10.1016/S0169-5002(01)00353-1 von Haag, 2002, Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer, J Surg Res, 103, 160, 10.1006/jsre.2002.6354 Nosotti, 2002, Role of (99m)tc-hexakis-2-methoxy-isobutylisonitrile in the diagnosis and staging of lung cancer, Chest, 122, 1361, 10.1378/chest.122.4.1361 Kiernan, 2002, Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography, South Med J, 95, 1168 Eggeling, 2002, Invasive staging of non-small cell lung cancer–a prospective study, Eur J Cardiothorac Surg, 22, 679, 10.1016/S1010-7940(02)00479-7 Schillaci, 2003, Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT, J Nucl Med, 44, 1219 Reed, 2003, Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer, J Thorac Cardiovasc Surg, 126, 1943, 10.1016/j.jtcvs.2003.07.030 Kimura, 2003, A prospective study of indications for mediastinoscopy in lung cancer with CT findings, tumor size, and tumor markers, Ann Thorac Surg, 75, 1734, 10.1016/S0003-4975(03)00035-3 Kelly, 2004, Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer, Chest, 125, 1413, 10.1378/chest.125.4.1413 Gould, 2003, Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis, Ann Intern Med, 139, 879, 10.7326/0003-4819-139-11-200311180-00013 Dwamena, 1999, Metastases from non-small cell lung cancer: mediastinal staging in the 1990s; meta-analytic comparison of PET and CT, Radiology, 213, 530, 10.1148/radiology.213.2.r99nv46530 1997, American Thoracic Society, European Respiratory Society.. Pretreatment evaluation of non-small cell lung cancer, Am J Respir Crit Care Med, 156, 320, 10.1164/ajrccm.156.1.ats156.1 2001, British Thoracic Society, Society of Cardiothoracic Surgeons of GB, Ireland Working Party.. Guidelines on the selection of patients with lung cancer for surgery, Thorax, 56, 89, 10.1136/thorax.56.2.89 Nolop, 1987, Glucose utilizationin vivoby human pulmonary neoplasms, Cancer, 60, 2682, 10.1002/1097-0142(19871201)60:11<2682::AID-CNCR2820601118>3.0.CO;2-H Weber, 1955, Glucose-6-phosphatase activity in normal, pre-cancerous, and neoplastic tissues, Cancer Res, 15, 105 Wahl, 1991, 18F-2 deoxy-2-fluoro-D-glucose uptake into human tumor xenografts: feasibility studies for cancer imaging with positron-emission tomography, Cancer, 67, 1544, 10.1002/1097-0142(19910315)67:6<1544::AID-CNCR2820670614>3.0.CO;2-0 Gupta, 2000, Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions, Chest, 117, 773, 10.1378/chest.117.3.773 Detterbeck, 2004, Seeking a home for a PET: part 2. Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer, Chest, 125, 2300, 10.1378/chest.125.6.2300 Detterbeck, 2004, Seeking a home for a PET: part 1. Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses, Chest, 125, 2294, 10.1378/chest.125.6.2294 Kim, 1998, Localized form of bronchioloalveolar carcinoma: FDG PET findings, AJR Am J Roentgenol, 170, 935, 10.2214/ajr.170.4.9530038 Higashi, 1998, Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma, J Nucl Med, 39, 1016 Gupta, 1996, Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET, J Nucl Med, 37, 943 Lardinois, 2003, Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography, N Engl J Med, 348, 2500, 10.1056/NEJMoa022136 Wahl, 1994, Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation, Radiology, 191, 371, 10.1148/radiology.191.2.8153308 Chin, 1995, Mediastinal staging of non-small-cell lung cancer with positron emission tomography, Am J Respir Crit Care Med, 152, 2090, 10.1164/ajrccm.152.6.8520780 Scott, 1996, Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography, J Thorac Cardiovasc Surg, 111, 642, 10.1016/S0022-5223(96)70317-3 Sazon, 1996, Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer, Am J Respir Crit Care Med, 153, 417, 10.1164/ajrccm.153.1.8542152 Steinert, 1997, Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling, Radiology, 202, 441, 10.1148/radiology.202.2.9015071 Guhlmann, 1997, Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography (PET), Thorax, 52, 438, 10.1136/thx.52.5.438 Magnani, 1999, FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients, J Cardiovasc Surg, 40, 741 Roberts, 2000, Factors associated with false-positive staging of lung cancer by positron emission tomography, Ann Thorac Surg, 70, 1154, 10.1016/S0003-4975(00)01769-0 Liewald, 2000, How useful is positron emission tomography for lymph node staging in non-small-cell lung cancer?, Thorac Cardiovasc Surg, 48, 93, 10.1055/s-2000-9870 Farrell, 2000, Non-small cell lung cancer: fDG PET for nodal staging in patients with stage I disease, Radiology, 215, 886, 10.1148/radiology.215.3.r00jn29886 Tatsumi, 2000, Evaluation of lung cancer by 99mTc-tetrofosmin SPECT: comparison with [18F]FDG-PET, J Comput Assist Tomogr, 24, 574, 10.1097/00004728-200007000-00011 Changlai, 2001, Whole body 18F-2-deoxyglucose positron emission tomography to restage non-small cell lung cancer, Oncol Rep, 8, 337 Vesselle, 2002, The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer, J Thorac Cardiovasc Surg, 124, 511, 10.1067/mtc.2002.123130 Kernstine, 2002, Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?, Ann Thorac Surg, 73, 394, 10.1016/S0003-4975(01)03432-4 Zimny, 2003, Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera, Eur Radiol, 13, 740, 10.1007/s00330-002-1582-0 Konishi, 2003, Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings, Respiration, 70, 500, 10.1159/000074207 Gonzalez-Stawinski, 2003, A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer, J Thor Cardiovasc Surg, 126, 1900, 10.1016/S0022-5223(03)01036-5 Fritscher-Ravens, 2003, Mediastinal lymph node involvement in potentially resectable lung cancer: comparison of CT, positron emission tomography, and endoscopic ultrasonography with and without fine-needle aspiration, Chest, 123, 442, 10.1378/chest.123.2.442 Demura, 2003, 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax, J Nucl Med, 44, 540 Halpern, 2005, Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion, Chest, 128, 2289, 10.1016/S0012-3692(15)52634-2 Mac Manus, 2001, High rate of unsuspected distant metastases by PET in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy, Int J Radiat Oncol Biol Phys, 50, 287, 10.1016/S0360-3016(01)01477-8 van Tinteren, 2002, Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small cell lung cancer: the PLUS Multicentre Randomised Trial, Lancet, 359, 1388, 10.1016/S0140-6736(02)08352-6 Dietlein, 2000, Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results, Eur J Nucl Med, 27, 1598, 10.1007/s002590000376 Spiro, 2002, Lung cancer: where are we today? Current advances in staging and nonsurgical treatment, Am J Respir Crit Care Med, 166, 1166, 10.1164/rccm.200202-070SO Scott, 1998, Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis, Ann Thorac Surg, 66, 1876, 10.1016/S0003-4975(98)01055-8 Antoch, 2003, Non-small cell lung cancer: dual modality PET/CT in preoperative staging, Radiology, 229, 526, 10.1148/radiol.2292021598 Roman, 2001, Staging and managing lung tumors using F-18 FDG coincidence detection, Clin Nucl Med, 26, 383, 10.1097/00003072-200105000-00001 Crisci, 1997, MR study of N2 disease in lung cancer: contrast-enhanced method using gadolinium-DTPA, Eur J Cardiothorac Surg, 11, 214, 10.1016/S1010-7940(96)01047-0 Kernstine, 1999, PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma, Ann Thorac Surg, 68, 1022, 10.1016/S0003-4975(99)00788-2 Padovani, 1993, Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging, Radiology, 187, 33, 10.1148/radiology.187.1.8451432 Heelan, 1989, Superior sulcus tumors: CT and MR imaging, Radiology, 170, 637, 10.1148/radiology.170.3.2916014 Manfredi, 1996, Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma, MAGMA, 4, 257, 10.1007/BF01772015 Shiotani, 2000, Diagnosis of chest wall invasion by lung cancer: useful criteria for exclusion of the possibility of chest wall invasion with MR imaging, Radiat Med, 20, 697 Silvestri, 1995, The clinical evaluation for detecting metastatic lung cancer: a meta-analysis, Am J Respir Crit Care Med, 152, 225, 10.1164/ajrccm.152.1.7599828 Osaki, 2002, Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage 1 non-small-cell lung cancer, J Clin Oncol, 20, 2930, 10.1200/JCO.2002.11.011 Passlick, 2003, Initial surgical staging of lung cancer, Lung Cancer, 42(suppl), S21, 10.1016/S0169-5002(03)00301-5 Cote, 1995, Detection of occult bone marrow micrometastases in patients with operable lung cancer, Ann Surg, 222, 415, 10.1097/00000658-199522240-00001 Ohgami, 1997, Micrometastatic tumor cells in the bone marrow of patients with non-small-cell lung cancer, Ann Thorac Surg, 64, 363, 10.1016/S0003-4975(97)00543-2 Pantel, 1996, Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer, Lancet, 347, 649, 10.1016/S0140-6736(96)91203-9 Jiao, 2002, Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology, Ann Thorac Surg, 74, 278, 10.1016/S0003-4975(01)03376-8 Arriagada, 2004, International Adjuvant Lung Cancer Trial Collaborative Group: cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer, N Engl J Med, 350, 351, 10.1056/NEJMoa031644 Hooper, 1984, Computed tomographic scanning in initial staging of bronchogenic carcinoma, Chest, 85, 774, 10.1378/chest.85.6.774 Hooper, 1978, Radioisotope scanning in the initial staging of bronchogenic carcinoma, Am Rev Respir Dis, 118, 279 Turner, 1981, Preoperative radionuclide scanning in bronchogenic carcinoma, Chest, 75, 291 Ramsdell, 1977, Multiorgan scans for staging lung cancer: correlation with clinical evaluation, J Thorac Cardiovasc Surg, 73, 653, 10.1016/S0022-5223(19)41459-1 Tanaka, 1999, Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1–2 N0, Ann Thorac Surg, 68, 1039, 10.1016/S0003-4975(99)00694-3 Bilgin, 2002, Extrathoracic staging of non-small cell bronchogenic carcinoma: relationship of the clinical evaluation to organ scans, Respirology, 7, 57, 10.1046/j.1440-1843.2002.00358.x Silvestri, 1992, The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma, Chest, 102, 1748, 10.1378/chest.102.6.1748 Grant, 1988, Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer, Thorax, 43, 883, 10.1136/thx.43.11.883 Tarver, 1984, Cerebral metastases from lung carcinoma: neurological and CT correlation work in progress, Radiology, 153, 689, 10.1148/radiology.153.3.6093189 Salvatierra, 1990, Extrathoracic staging of bronchogenic carcinoma, Chest, 97, 1052, 10.1378/chest.97.5.1052 Hillers, 1994, Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer, Thorax, 49, 14, 10.1136/thx.49.1.14 Herder, 2002, Practice, efficacy and cost of staging suspected non-small-cell lung cancer: a retrospective study in two Dutch hospitals, Thorax, 57, 11, 10.1136/thorax.57.1.11 Pagani, 1984, Non-small cell lung carcinoma adrenal metastases-computed tomography and percutaneous needle biopsy in their diagnosis, Cancer, 53, 1058, 10.1002/1097-0142(19840301)53:5<1058::AID-CNCR2820530507>3.0.CO;2-N Allard, 1990, Sensitivity and specificity of computed tomography for the detection of adrenal metastatic lesions among 91 autopsied lung cancer patients, Cancer, 66, 457, 10.1002/1097-0142(19900801)66:3<457::AID-CNCR2820660310>3.0.CO;2-R Quinn, 1986, Staging of non-small cell bronchogenic carcinoma - relationship of the clinical evaluation to organ scans, Chest, 89, 270, 10.1378/chest.89.2.270 Guyatt, 1999, Surgeons' assessment of symptoms suggesting extrathoracic metastases in patients with lung cancer, Ann Thorac Surg, 68, 309, 10.1016/S0003-4975(99)00324-0 Shahidi, 1996, Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer, Chest, 109, 271, 10.1378/chest.109.1.271 Urchel, 1997, Long-term survival after bilateral adrenalectomy for metastatic lung cancer: a case report, Chest, 112, 848, 10.1378/chest.112.3.848 Ichinose, 1989, Preoperative examination to detect distant metastases is not advocated for asymptomatic patients with stages I and II non-small cell lung cancer: preoperative examination for lung cancer, Chest, 96, 1104, 10.1378/chest.96.5.1104 Hatter, 1994, Preopertive evaluation of stage I and stage II non-small-cell lung cancer, Ann Thorac Surg, 58, 1738, 10.1016/0003-4975(94)91673-X 2001, Canadian Lung Oncology Group.. Investigating extrathoracic metastatic disease in patients with apparently operable lung cancer, Ann Thorac Surg, 71, 425, 10.1016/S0003-4975(00)02359-6 Graeber, 1999, Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease, J Thorac Cardiovasc Surg, 117, 719, 10.1016/S0022-5223(99)70292-8 Gupta, 1999, Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer, Ann Surg, 229, 286, 10.1097/00000658-199902000-00018 Verboom, 2002, Staging of non-small-cell lung cancer and applecation of FDG-PET: a cost modeling approach, Int J Technol Assess Health Care, 18 Weder, 1998, Detection of extrathoracic metastases by positron emission tomography in lung cancer, Ann Thorac Surg, 66, 886, 10.1016/S0003-4975(98)00675-4 Erasmus, 1997, Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography, AJR Am J Roentgenol, 168, 1357, 10.2214/ajr.168.5.9129444 Bury, 1998, Flourine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small-cell lung cancer, Eur J Nucl Med, 25, 1244, 10.1007/s002590050291 Larcos, 1996, FDG-PET screening for cerebral metastases in patients with suspected malignancy, Nucl Med Commun, 212, 803 Hicks, 2001, 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer, J Nucl Med, 42, 1596 Valk, 1996, Cost-effectiveness of PET imaging in clinical oncology, Nucl Med Biol, 23, 737, 10.1016/0969-8051(96)00080-7 Verboom, 2003, Cost-effectiveness of FDG-PET in staging non-small-cell lung cancer: the PLUS study, Eur J Nucl Med Mol Imaging, 30, 1444, 10.1007/s00259-003-1199-9 Stroobants, 2003, Additional value of whole-body fluorodeoxyglucose positron emission tomography in the detection of distant metastases of non-small-cell lung cancer, Clin Lung Cancer, 4, 242, 10.3816/CLC.2003.n.005 Hany, 2002, PET diagnostic accuracy: improvement with in-line PET-CT system; initial results, Radiology, 225, 575, 10.1148/radiol.2252011568 Nielson, 1982, Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma, AJR Am J Roentgenol, 139, 317, 10.2214/ajr.139.2.317 Chapman, 1984, Upper abdominal computerized tomography scanning in staging non-small cell lung carcinoma, Cancer, 54, 1541, 10.1002/1097-0142(19841015)54:8<1541::AID-CNCR2820540812>3.0.CO;2-N Pearlberg, 1985, T1N0M0 bronchogenic carcinoma: assessment by CT, Radiology, 157, 187, 10.1148/radiology.157.1.4034964 Heavey, 1986, The role of CT in staging radiographic T1N0M0 lung cancer, AJR Am J Roentgenol, 146, 285, 10.2214/ajr.146.2.285 Osada, 1987, The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer, Jpn J Surg, 17, 362, 10.1007/BF02470635 Mirvis, 1987, Abdominal CT in the staging of small-cell carcinoma of the lung: incidence of metastases and effect on prognosis, AJR Am J Roentgenol, 148, 845, 10.2214/ajr.148.5.845 Whittlesey, 1988, Prospective computed tomographic scanning in the staging of bronchogenic cancer, J Thorac Cardiovasc Surg, 95, 876, 10.1016/S0022-5223(19)35700-9 Ettinghausen, 1991, Prospective evaluation of unilateral adrenal masses in patients with operable non-small cell lung cancer, J Clin Oncol, 9, 1462, 10.1200/JCO.1991.9.8.1462 Miralles, 1993, Percutaneous fine needle aspiration biopsy cytology of the liver for staging small cell lung carcinoma: comparison with other methods, Acta Cytol, 37, 499 Goerg, 1992, Adrenal masses in lung cancer: sonographic diagnosis and follow-up, Eur J Cancer, 28A, 1400, 10.1016/0959-8049(92)90529-B Oliver, 1984, Isolated adrenal masses in non-small cell bronchogenic carcinoma, Radiology, 153, 217, 10.1148/radiology.153.1.6473783 Burt, 1994, Prospective evaluation of unilateral adrenal masses in patients with operable non-small cell lung cancer: impact of magnetic resonance imaging, J Thorac Cardiovasc Surg, 107, 584, 10.1016/S0022-5223(94)70106-7 Eggesbo, 1996, Clinical impact of adrenal expansive lesions in bronchial carcinoma, Acta Radiol, 37, 343, 10.1177/02841851960371P172 Boland, 1995, Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-(F-18)-fluoro-2-deoxy-D-glucose, Radiology, 194, 131, 10.1148/radiology.194.1.7997539 Gillams, 1992, The value of CT scanning and percutaneous fine needle aspiration of adrenal masses in biopsy-proven lung cancer, Clin Radiol, 46, 18, 10.1016/S0009-9260(05)80027-3 Macari, 1998, Non-small cell lung carcinoma: usefulness of unenhanced helical CT of the adrenal glands in an unmonitored environment, Radiology, 209, 807, 10.1148/radiology.209.3.9844679 Porte, 1999, Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small cell lung cancer, Eur J Cardiothorac Surg, 15, 597, 10.1016/S1010-7940(99)00047-0 Heinz-Peer, 1999, Characterization of adrenal masses using MR imaging with histopathologic correlation, AJR Am J Roentgenol, 173, 15, 10.2214/ajr.173.1.10397092 Gross, 1988, Distinguishing benign from malignant euadrenal masses, Ann Intern Med, 109, 613, 10.7326/0003-4819-109-8-613 Butler, 1979, The value of routine cranial computed tomography in neurologically intact patients with primary carcinoma of the lung, Radiology, 131, 339, 10.1148/131.2.399 Cole, 1994, Cerebral imaging in the asymptomatic preoperative bronchogenic carcinoma patient: is it worthwhile?, Ann Thorac Surg, 57, 838, 10.1016/0003-4975(94)90185-6 Colice, 1995, Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases, Chest, 108, 1264, 10.1378/chest.108.5.1264 Jacobs, 1977, ‘Silent’ brain metastasis from lung carcinoma determined by computerized tomography, Arch Neurol, 77, 690, 10.1001/archneur.1977.00500230060010 Mintz, 1984, Intracranial metastases in the initial staging of bronchogenic carcinoma, Chest, 86, 850, 10.1378/chest.86.6.850 Ferrigno, 1994, Cranial computed tomography as a part of the initial staging procedures for patients with non-small cell lung cancer, Chest, 106, 1025, 10.1378/chest.106.4.1025 Kormas, 1992, Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma, Thorax, 47, 106, 10.1136/thx.47.2.106 Jennings, 1980, Asymptomatic patients with primary carcinoma; computerized axial tomography study, N Y State J Med, 80, 1096 Johnson, 1983, Limited value of CT brain scans in the staging of small cell lung cancer, AJR Am J Roentgenol, 140, 37, 10.2214/ajr.140.1.37 Levitan, 1984, Role of computerized cranial tomography in the staging of small cell carcinoma of the lung, Cancer Treat Rep, 68, 1375 Crane, 1984, A comparison of computed tomography and radionuclide scanning for detection of brain metastases in small cell lung cancer, J Clin Oncol, 2, 1017, 10.1200/JCO.1984.2.9.1017 Habets, 1992, Diagnostic value of CT in the detection of brain metastasis in small cell lung cancer patients, J Belge Radiol, 75, 179 Yokio, 1999, Detection of brain ‘metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI, Chest, 115, 714, 10.1378/chest.115.3.714 Patchell, 1990, A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, 322, 494, 10.1056/NEJM199002223220802 Davis, 1991, Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging, AJR Am J Roentgenol, 156, 1039 Earnest, 1999, Suspected non-small cell lung cancer: incidence of occult brain and skeletal metastases and effectiveness of imaging for detection: pilot study, Radiology, 211, 137, 10.1148/radiology.211.1.r99ap34137 Hochstenbag, 2003, MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung: does it influence prognosis and treatment?, Lung Cancer, 42, 189, 10.1016/S0169-5002(03)00291-5 Griffeth, 1993, Brain metastases from non-central nervous system tumors: evaluation with PET, Radiology, 186, 37, 10.1148/radiology.186.1.8416584 Tornyos, 1991, A correlation study of bone scanning with clinical and laboratory findings in the staging of non-small cell lung cancer, Clin Nucl Med, 16, 107, 10.1097/00003072-199102000-00009 Michel, 1991, Initial staging of non-small cell lung cancer; value of routine radioisotope bone scanning, Thorax, 46, 469, 10.1136/thx.46.7.469 Schirrmeister, 2004, Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer, Eur J Nucl Med Mol Imaging, 31, 964, 10.1007/s00259-004-1492-2 Hsia, 2002, Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer, Neoplasma, 49, 267 Carretta, 2002, Therapeutic strategy in patients with non-small cell lung cancer associated to satellite pulmonary nodules, Eur J Cardiothorac Surg, 21, 1100, 10.1016/S1010-7940(02)00108-2 Erasmus, 2000, FDG PET of pleural effusions in patients with non-small cell lung cancer, AJR Am J Roentgenol, 175, 245, 10.2214/ajr.175.1.1750245 Gupta, 2002, Clinical role of F-18 fluorodeoxyglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion, Chest, 122, 1918, 10.1378/chest.122.6.1918 Duysinx, 2004, Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging, Chest, 125, 489, 10.1378/chest.125.2.489 Berlangieri, 1999, F-18 fluorodeoxyglucose position emission tomography in the non-invasive staging of non-small cell lung cancer, Eur J Cardiothorac Surg, 16(suppl), S25, 10.1016/S1010-7940(99)00179-7 Kobayashi, 1995, Evaluation of lymph nodes on computed tomography images in epidermoid lung cancer, Intern Med, 34, 507, 10.2169/internalmedicine.34.507 Seely, 1993, T1 lung cancer: prevalence of mediastinal modal metastases and diagnostic accuracy of CT, Radiology, 186, 129, 10.1148/radiology.186.1.8416552 Izbicki, 1992, Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma: a prospective study, J Thorac Cardiovasc Surg, 104, 413, 10.1016/S0022-5223(19)34797-X Yasukawa, 2000, Usefulness of PET with11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer, J Nucl Med, 41, 283 Sasaki, 1996, The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with nonsmall cell lung cancer: a comparative study with x-ray computed tomography, Eur J Nucl Med, 23, 741, 10.1007/BF00843701